PharmaCyte Biotech, Inc. - Common Stock (PMCB) is currently showing a neutral headline tone with a mixed / range backdrop. The latest news flow is being framed here as context rather than prediction, so beginners can quickly see whether headlines are helping, hurting, or complicating the chart story. Earnings tone is currently no clear earnings read.
HEADLINE TAKE: The current headline mix looks balanced, so the overall news tone reads neutral right now.
Change stock
Search another ticker to view its latest news page.
Full chart, indicators and drawing tools on TradingView. Move to Platforms when you are ready to act.
MyStockHarbor
NEWS SCORE
43/100
Neutral
Bearish
Neutral
Bullish
Earnings Tone
55
Neutral based on actual EPS/revenue
Confidence
Medium
Headline depth
Last Price
DATA UNAVAILABLE
Trend Context
Mixed / range
Latest briefing
What's happening with PMCB
Investing.com7 Jan 2026
Pharmacyte Biotech CEO Silverman buys $80k in shares - Investing.com
<a href="https://news.google.com/rss/articles/CBMitwFBVV95cUxNdFFTeF94bVdRSjBMQjF2N0dGdF92N1M1YUVZbW9zNnMyNVhvREZzeEoybXdNdzA4Mjc3bE56a2V6LS1NTzJsQlVLWDNlREZlWXJhWWl1Y1hHVC1EVk1JajlaRkQ0WnJDNWs3ODZNbHM3WXlKWl9TZXBDMGdra1QxdWdPV1BIdVhjdU81a1hicjJfMU5tUURvZzdxMWpfbHdSX2xVSEUyZU5YNXBlMDBHdkRWWlNLam8?oc=5" target="_blank">Pharmacyte Biotech CEO Silverman buys $80k in shares</a> <font color="#6f6f6f">Investing.com</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
StocksToTrade4 Dec 2025
PharmaCyte Biotech: Is Growth Here to Stay? - StocksToTrade
<a href="https://news.google.com/rss/articles/CBMigAFBVV95cUxPMzdoOHF6ejlacjFUZkJ2YWhFbDRrTzFwaFV4SVpvaFI2NXJDNXJqMzVza0J3dTlOYXItNjJ1OGFLczgxZGZVbEZiZFFid1p3bnVCTWkwazlKbjFXeGZGUEluYVQ0cEpRdjREMFZBR19aeGJqbWNMMEFyQTZWcDVUTg?oc=5" target="_blank">PharmaCyte Biotech: Is Growth Here to Stay?</a> <font color="#6f6f6f">StocksToTrade</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Stocktwits25 Nov 2025
PMCB Stock Jumps 25% After Company Sells Stake In Femasys - Stocktwits
<a href="https://news.google.com/rss/articles/CBMiuAFBVV95cUxOaVhHemV5UjdsaU11Z0poUDRkczkwdmdnbWY2NkZtTmpkbk5sQ1g1LUFnOXlRTThtUGU3NU9OS1U1aHQtOE9xMGVfNTQtSjN3Mkw3MHdNSi0zdDZPNXFwTHpoNk94ekhzZjZNaWRLdzhmRm96MUtBYWJRaU9GQW5fZmd1V2pSV0xtaTI0TjVZcVllV1FLN2dOUzZMbExsYnVnZ2NSSTRtLWNIR2Z5WkhxdHdHa1g5WDAx?oc=5" target="_blank">PMCB Stock Jumps 25% After Company Sells Stake In Femasys</a> <font color="#6f6f6f">Stocktwits</font>
Article excerpt provided by the FMP news feed. AI is used only for the optional "Why this matters" read.Read full article ↗
Older updates drop into a lighter feed
Investing News Network
12 Sept 2025
PharmaCyte Biotech, Inc. Announces $7 Million Capital Raise Led by Existing Investors - Investing News Network
